Baxter
BAX
#2139
Rank
NZ$15.08 B
Marketcap
NZ$29.22
Share price
6.33%
Change (1 day)
-50.98%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

P/S ratio for Baxter (BAX)

P/S ratio as of March 2026 (TTM): 0.7713

According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.42. At the end of 2025 the company had a P/S ratio of 0.8915.

P/S ratio history for Baxter from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.8915-36.4%
20241.40-2.06%
20231.43-17.58%
20221.74-48.35%
20213.36-4.25%
20203.51-5.74%
20193.7322.69%
20183.04-8.95%
20173.3340.52%
20162.3713.22%
20152.10-19.94%
20142.625.33%
20132.49-3.13%
20122.5727.77%
20112.01-12.26%
20102.29-18.46%
20092.814.3%
20082.69-17.69%
20073.2712.46%
20062.9121.72%
20052.396.43%
20042.246.73%
20032.100.67%
20022.09-50.16%
20014.19

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Medtronic
MDT
3.14 306.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
4.10 431.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.60 236.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
4.65 502.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
5.01 549.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
0.2032-73.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
1.43 85.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
5.48 610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
0.0323-95.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CryoLife
CRY
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA